API 99%CAS: 171596-29-5 Tadalafil Pharmaceutical Raw Materials

Model NO.: CAS: 171596-29-5
Trademark: dky
Transport Package: Aluminum Foil or Cardboard Barrels
Specification: Pharmaceutical grade
Origin: Dky
Model NO.: CAS: 171596-29-5
Trademark: dky
Transport Package: Aluminum Foil or Cardboard Barrels
Specification: Pharmaceutical grade
Origin: Dky
API 99%CAS: 171596-29-5 Tadalafil Pharmaceutical Raw Materials

API 99%CAS: 171596-29-5 Tadalafil pharmaceutical raw materials


Name: Si Li Shi
Alias: his darling
Name: Tadalafil
CAS: 171596-29-5
Molecular formula: C22H19N3O4
Molecular weight: 389.4
Physicochemical properties: melting process: 298-300
He can take it directly, but if you want to know the usage and dosage, you can't take it as following.
1. it is not known that patients who are allergic to the drug and their constituents are not allowed to take this product.
2. clinical studies have shown that TEDA can improve the antihypertensive effect of nitrates. This is believed to be the result of the interaction of nitrates and cGMP on the nitric oxide pathway. Therefore, patients who are taking any form of nitrate medicine are prohibited from taking this product.
Sexual life can bring potential heart risks to heart disease patients. Therefore, the treatment of erectile dysfunction, including his name, is not applicable to patients with heart disease that are not recommended for sexual life. For patients with heart disease, doctors should consider potential cardiac risks in sexual life.
Note: 1. prior to the consideration of drug treatment, medical history and a physical examination should be conducted to diagnose erectile dysfunction and determine possible unknown causes. Since the risk of cardiovascular disease is related to a certain degree of sexual behavior, doctors should consider the patient's cardiovascular health before treatment for erectile dysfunction, including his darling. Because of its characteristics of vasodilatation, it will cause mild and transient blood pressure lowering, which may enhance the effect of nitrate lowering.
2. serious cardiovascular diseases, including myocardial infarction, unstable angina, ventricular arrhythmia, shock, and transient ischemic attack, have been observed in a clinical trial of taillago. In addition, hypertension and hypotension (including orthostatic hypotension) can be seen occasionally in clinical trials. Most of these patients had cardiovascular factors before taking drugs. However, it is not yet clear whether these events are associated with these risk factors.
3. visual impairment and non arteria anterior ischemic optic neuropathy (NAION) have been reported to be associated with the use of PDE5 and other inhibitors. Patients should be informed of sudden visual impairment. They should stop using Dr Da La Fei and consult a doctor immediately.
4. the clinical safety information for patients with severe liver dysfunction (Child-Pugh grade C) using this product is limited; if a prescription is prescribed for such patients, a prescription doctor requires a serious benefit / risk assessment for each patient.
5. patients should be advised to seek treatment immediately after erection for more than 4 hours or longer. If the priapism is not treated in time, it may lead to the destruction of the penile tissue and permanent erectile dysfunction.
More than 6. of the patients should be cautious with his deformable patients (such as sickle cell anemia, multiple myeloma or leukemia), or patients with abnormal penis (such as penis angle, malformed penis, cavernous fibrosis, or Peyronie disease).
7. the diagnosis of erectile dysfunction should include identifying the underlying causes and determining the appropriate treatment after appropriate assessment.
8. it is unclear whether this product is effective for patients with spinal cord injuries, those with pelvic surgery and those with prostatectomy.
9. he can not be used in the following patients: a patient with a hereditary problem with galactose intolerance, or a patient with a laclacerase deficiency, or a glucose - galactose poor patient.
10. (1) receptor blockers such as doxazosin, such as the combined use of this product, may lead to symptomatic hypotension in some patients (detailed "drug interaction"). Therefore, it is not recommended that he should be combined with blockers.
11. special attention should be paid to patients who are using powerful CYP3A4 inhibitors, such as Lito Bernard Vee, Shah Que Bernard Vee, ketoconazole, itraconazole, and erythromycin, to prescribe the prescriptions of TEDA. Since the combination of such drugs has been found, the safety and efficacy of the combination of AUC and other erectile dysfunction therapy has not been studied. Therefore, this kind of combined use is not recommended.







  API 99%CAS: 171596-29-5 Tadalafil Pharmaceutical Raw Materials

API 99%CAS: 171596-29-5 Tadalafil pharmaceutical raw materials


Name: Si Li Shi
Alias: his darling
Name: Tadalafil
CAS: 171596-29-5
Molecular formula: C22H19N3O4
Molecular weight: 389.4
Physicochemical properties: melting process: 298-300
He can take it directly, but if you want to know the usage and dosage, you can't take it as following.
1. it is not known that patients who are allergic to the drug and their constituents are not allowed to take this product.
2. clinical studies have shown that TEDA can improve the antihypertensive effect of nitrates. This is believed to be the result of the interaction of nitrates and cGMP on the nitric oxide pathway. Therefore, patients who are taking any form of nitrate medicine are prohibited from taking this product.
Sexual life can bring potential heart risks to heart disease patients. Therefore, the treatment of erectile dysfunction, including his name, is not applicable to patients with heart disease that are not recommended for sexual life. For patients with heart disease, doctors should consider potential cardiac risks in sexual life.
Note: 1. prior to the consideration of drug treatment, medical history and a physical examination should be conducted to diagnose erectile dysfunction and determine possible unknown causes. Since the risk of cardiovascular disease is related to a certain degree of sexual behavior, doctors should consider the patient's cardiovascular health before treatment for erectile dysfunction, including his darling. Because of its characteristics of vasodilatation, it will cause mild and transient blood pressure lowering, which may enhance the effect of nitrate lowering.
2. serious cardiovascular diseases, including myocardial infarction, unstable angina, ventricular arrhythmia, shock, and transient ischemic attack, have been observed in a clinical trial of taillago. In addition, hypertension and hypotension (including orthostatic hypotension) can be seen occasionally in clinical trials. Most of these patients had cardiovascular factors before taking drugs. However, it is not yet clear whether these events are associated with these risk factors.
3. visual impairment and non arteria anterior ischemic optic neuropathy (NAION) have been reported to be associated with the use of PDE5 and other inhibitors. Patients should be informed of sudden visual impairment. They should stop using Dr Da La Fei and consult a doctor immediately.
4. the clinical safety information for patients with severe liver dysfunction (Child-Pugh grade C) using this product is limited; if a prescription is prescribed for such patients, a prescription doctor requires a serious benefit / risk assessment for each patient.
5. patients should be advised to seek treatment immediately after erection for more than 4 hours or longer. If the priapism is not treated in time, it may lead to the destruction of the penile tissue and permanent erectile dysfunction.
More than 6. of the patients should be cautious with his deformable patients (such as sickle cell anemia, multiple myeloma or leukemia), or patients with abnormal penis (such as penis angle, malformed penis, cavernous fibrosis, or Peyronie disease).
7. the diagnosis of erectile dysfunction should include identifying the underlying causes and determining the appropriate treatment after appropriate assessment.
8. it is unclear whether this product is effective for patients with spinal cord injuries, those with pelvic surgery and those with prostatectomy.
9. he can not be used in the following patients: a patient with a hereditary problem with galactose intolerance, or a patient with a laclacerase deficiency, or a glucose - galactose poor patient.
10. (1) receptor blockers such as doxazosin, such as the combined use of this product, may lead to symptomatic hypotension in some patients (detailed "drug interaction"). Therefore, it is not recommended that he should be combined with blockers.
11. special attention should be paid to patients who are using powerful CYP3A4 inhibitors, such as Lito Bernard Vee, Shah Que Bernard Vee, ketoconazole, itraconazole, and erythromycin, to prescribe the prescriptions of TEDA. Since the combination of such drugs has been found, the safety and efficacy of the combination of AUC and other erectile dysfunction therapy has not been studied. Therefore, this kind of combined use is not recommended.







 

Seed

Organic White Sesame Seeds,Organic Sesame Seeds,White Sesame Seeds

Xianfeng Agricultural And Forestry Products Co., Ltd. , http://www.sx-honey.com

Posted on